http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113325173-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54326 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate | 2020-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113325173-B |
| titleOfInvention | Novel coronavirus detection kit |
| abstract | The invention relates to a novel coronavirus detection kit, which comprises a magnetic bead component, a luminescent component and a neutralizing antigen component; the magnetic bead component contains an anti-human IgM antibody-magnetic bead complex; the luminescent component contains an anti-mouse IgG Fc segment antibody, and a luminescent marker is marked on the anti-mouse IgG Fc segment antibody; the neutralizing antigen component contains fusion protein, and the fusion protein has the Spike protein sequence shown in SEQ ID No. 1 and the mouse IgG1 antibody Fc segment sequence shown in SEQ ID No. 2 successively from N end to C end. The novel coronavirus detection kit disclosed by the invention is based on the principle of a two-step capture immunization method of a direct chemiluminescence technology, and can be used for quickly judging the concentration of the novel coronavirus IgM antibody in a sample to be detected by using a corresponding chemiluminescence determinator. |
| priorityDate | 2020-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 411.